ChemDiv shares an update on its Cutting-edge Biology Facility in Portugal
ChemDiv, one of the leading global contract research organizations (CROs), has announced a significant update on its cutting-edge biology facility in Portugal. The state-of-the-art facility is designed to provide advanced drug discovery services to clients in the pharmaceutical and biotech industries worldwide.
The facility is equipped with advanced technologies and specialized equipment to offer various services such as assay development, high-throughput screening, hit identification and profiling, pharmacology and discovery biology, among other services. The facility combines the latest in automation, bioinformatics, and screening technologies to deliver high-quality data and rapid results.
Here are some key points about the facility:
World-class infrastructure and equipment
The purpose-built building spans 3,000 square meters and is equipped with four fully-automated screening platforms, which together can handle millions of compounds. The facility is equipped with the latest in robotic liquid handling, high-content imaging, and cellular assay technologies, which will enable clients to accelerate their drug discovery programs and deliver novel therapeutics to patients.
Expert team of scientists
The facility is staffed by a team of world-class scientists who have extensive expertise in various aspects of drug discovery, including assay development, high-throughput screening, pharmacology, and medicinal chemistry. The team has decades of experience in the industry and has worked on numerous successful drug discovery programs.
Focus on innovation and collaboration
The facility is designed to foster innovation and collaboration. It is a flexible and adaptive space that can be customized to meet a wide range of client needs. ChemDiv’s scientists work closely with clients to understand their specific requirements and tailor their services accordingly. The facility also offers clients access to ChemDiv’s extensive compound collection, which includes over 1 million compounds.
Commitment to quality and data integrity
ChemDiv’s biology facility is committed to providing high-quality data. The facility is set up to ensure data integrity, including robust quality control measures and monitoring procedures. All technicians are highly trained and comply with the highest standards of best practice.
In conclusion, ChemDiv’s cutting-edge biology facility in Portugal is a state-of-the-art facility designed to provide clients with advanced drug discovery services. The facility represents a significant investment in infrastructure and expertise and supports ChemDiv’s commitment to innovation and collaboration. The facility will help clients accelerate their drug discovery programs and deliver novel therapeutics to patients.